NYSE - Nasdaq Real Time Price USD

Haemonetics Corporation (HAE)

Compare
62.84
-1.20
(-1.87%)
As of 12:54:07 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,373,515
1,309,055
1,168,660
993,196
870,463
Cost of Revenue
641,701
617,507
553,563
487,694
472,625
Gross Profit
731,814
691,548
615,097
505,502
397,838
Operating Expense
542,970
518,246
459,446
434,355
340,903
Operating Income
188,844
173,302
155,651
71,147
56,935
Net Non Operating Interest Income Expense
-15,677
-13,018
-14,630
-17,121
-16,834
Other Income Expense
--
-8,419
382
9,603
32,812
Pretax Income
164,748
151,865
141,403
63,629
72,913
Tax Provision
34,683
34,307
26,002
20,254
-6,556
Net Income Common Stockholders
130,065
117,558
115,401
43,375
79,469
Diluted NI Available to Com Stockholders
130,065
117,558
115,401
43,375
79,469
Basic EPS
2.56
2.32
2.27
0.85
1.57
Diluted EPS
2.54
2.29
2.24
0.84
1.55
Basic Average Shares
50,728.50
50,706
50,783
51,047
50,688
Diluted Average Shares
51,212.50
51,397
51,420
51,353
51,292
Total Operating Income as Reported
180,425
164,883
156,033
80,750
89,747
Total Expenses
1,184,671
1,135,753
1,013,009
922,049
813,528
Net Income from Continuing & Discontinued Operation
130,065
117,558
115,401
43,375
79,469
Normalized Income
136,711.62
124,074.31
115,089.29
36,828.77
55,516.24
Interest Expense
15,677
13,018
14,630
17,121
16,834
Net Interest Income
-15,677
-13,018
-14,630
-17,121
-16,834
EBIT
180,425
164,883
156,033
80,750
89,747
EBITDA
295,442
262,098
249,340
178,497
174,034
Reconciled Cost of Revenue
574,074
552,323
492,896
437,361
421,168
Reconciled Depreciation
115,017
97,215
93,307
97,747
84,287
Net Income from Continuing Operation Net Minority Interest
130,065
117,558
115,401
43,375
79,469
Total Unusual Items Excluding Goodwill
-8,419
-8,419
382
9,603
32,812
Total Unusual Items
-8,419
-8,419
382
9,603
32,812
Normalized EBITDA
303,861
270,517
248,958
168,894
141,222
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,772.38
-1,902.69
70.29
3,056.77
8,859.24
3/31/2021 - 5/10/1991

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OFIX Orthofix Medical Inc.
15.84
-2.82%
 
CNMD CONMED Corporation
59.27
-1.93%
 
IART Integra LifeSciences Holdings Corporation
20.57
-5.56%
 
STE STERIS plc
222.82
-2.09%
 
LIVN LivaNova PLC
37.94
-3.96%
 
AVNS Avanos Medical, Inc.
14.14
-2.62%
 
SNN Smith & Nephew plc
28.17
+0.14%
 
CBLL CeriBell, Inc.
18.48
-3.95%
 
SRDX Surmodics, Inc.
29.97
-2.57%
 
TNDM Tandem Diabetes Care, Inc.
17.44
-7.68%